"No compromising on product safety” is the overriding principle for companies of the pharmaceutical industry and for allied enterprises in the packaging sector. Because of their high responsibility for human health, they are strictly monitored and have to comply with numerous specifications and guidelines. Not a small challenge for the companies. From an economic point of view, this sector can still be pleased with a market experiencing stable growth. But the industry has to move with the times.
Rising life expectancy, the increase in chronic diseases and the introduction of new and often very expensive forms of treatment have been responsible for strong growth in the last few years. More and more diseases are becoming treatable. Even for rare disorders with relatively small numbers of cases, more and more medications are being developed for which manufacturers are called upon to achieve greater complexity with ever smaller batch sizes. There is a trend away from standardization and towards individualized treatment. For plant manufacturers and packaging system suppliers, the high flexibility and rapid retooling already demanded in the market is thus intensifying further.